Literature DB >> 10571608

The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors.

M Woodward1, C E Morrison, K E McColl.   

Abstract

AIMS: To determine the prevalence of dyspepsia and associated antisecretory medication usage, and their associations with H. pylori infection in the general population. In addition, to compare the importance of H. pylori infection relative to other potential causes of dyspepsia: alcohol, smoking and obesity.
METHODS: The study examined a random population sample of 784 men and 827 women from Glasgow. They completed a validated dyspepsia questionnaire and had their H. pylori status determined by serology.
RESULTS: The overall prevalence of dyspepsia was 12%; prescribed antisecretory medication had been used over the last 6 months by 7%. The odds ratio (95% CI) for dyspepsia, comparing H. pylori-positives to negatives was 1.79 (1.03, 3.09) for men and 1.11 (0.70, 1.78) for women. Ever-smoking (both sexes) and obesity (women) had higher odds ratios for dyspepsia than did H. pylori. Adjustment for age, social class, ever-smoking, ever-drinking and obesity reduced the H. pylori odds ratios for dyspepsia to 1.38 (0.73, 2.60) for men and 0.99 (0. 57, 1.73) for women. The association between H. pylori and antisecretory medication usage was similar to that for dyspepsia.
CONCLUSION: Obesity and smoking are more important risk factors, for dyspepsia and antisecretory medication usage, than is H. pylori. Reducing the burden and cost of dyspepsia will require lifestyle modification and not merely H. pylori eradication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571608     DOI: 10.1046/j.1365-2036.1999.00632.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  Evaluation of Helicobacter pylori status and endoscopic findings among new outpatients with dyspepsia in Japan.

Authors:  Seiji Shiota; Kazunari Murakami; Akiko Takayama; Shigeaki Yasaka; Tadayoshi Okimoto; Aoi Yoshiiwa; Masaaki Kodama; Toshio Fujioka
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

3.  Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults.

Authors:  P Bytzer; S Howell; M Leemon; L J Young; M P Jones; N J Talley
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

4.  A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.

Authors:  Ruth Davies; David Crabbe; Paul Roderick; Jonathan R Goddard; James Raftery; Praful Patel
Journal:  Health Care Manag Sci       Date:  2002-11

5.  From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2014-04-09       Impact factor: 3.199

6.  Risk factors for un-investigated dyspepsia among primary care patients in northern Nigeria.

Authors:  O A Solomon; A O Ajayi
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

7.  Association Between Body Mass Index and Functional Dyspepsia in Young Japanese People.

Authors:  Yasunori Yamamoto; Shinya Furukawa; Junichi Watanabe; Aki Kato; Katsunori Kusumoto; Eiji Takeshita; Yoshio Ikeda; Naofumi Yamamoto; Katsuhiko Kohara; Yuka Saeki; Yoichi Hiasa
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.